Lung Hydatid Cyst

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 1527 Experts worldwide ranked by ideXlab platform

M Hokelek - One of the best experts on this subject based on the ideXlab platform.

  • comparison of the protoscolocidal effectiveness of hypertonic saline povidone iodine and albendazole solutions in an experimental Lung Hydatid Cyst model
    Journal of International Medical Research, 2011
    Co-Authors: Durgun T Yetim, Ahmet Basoglu, Ibrahim Yetim, Taslak A Sengul, Serdar O Bekdemir, M Hokelek
    Abstract:

    Secondary Hydatidosis is an important problem encountered during the surgical treatment of Hydatid Cysts. This study describes an experimental model of secondary Hydatidosis by Cyst inoculation, used to explore whether simultaneous inoculation of protoscolocidal agents could prevent secondary Hydatidosis. Fertile Cyst fluid was injected into the pleural space of rabbits alone (group 1, n = 8), and in combination with 2% albendazole solution (group 2, n = 8), 20% hypertonic saline (group 3, n = 8) or 10% povidone-iodine (group 4, n = 8). Computed tomography imaging of the thorax, indirect haemagglutination (IHA) titres and eosinophil counts were used to determine Cyst development. After 16 months, three control rabbits had pneumothorax, seven had Cysts and four had parenchymal nodules. Histopathological investigation of nodules revealed 87.5% Cyst formation. Pleural thickening was observed in rabbits from all groups. Cyst formation rates, IHA titres and eosinophilia counts were higher in group 1 than in groups 2-4. This study demonstrated the experimental formation of secondary Hydatidosis and found that topical protoscolocidal agents were beneficial in preventing Cyst recurrence.

  • Comparison of the Protoscolocidal Effectiveness of Hypertonic Saline, Povidone—Iodine and Albendazole Solutions in an Experimental Lung Hydatid Cyst Model
    Journal of International Medical Research, 2011
    Co-Authors: T Durgun Yetim, Ahmet Basoglu, A Taslak Sengul, Ibrahim Yetim, O Serdar Bekdemir, M Hokelek
    Abstract:

    Secondary Hydatidosis is an important problem encountered during the surgical treatment of Hydatid Cysts. This study describes an experimental model of secondary Hydatidosis by Cyst inoculation, used to explore whether simultaneous inoculation of protoscolocidal agents could prevent secondary Hydatidosis. Fertile Cyst fluid was injected into the pleural space of rabbits alone (group 1, n = 8), and in combination with 2% albendazole solution (group 2, n = 8), 20% hypertonic saline (group 3, n = 8) or 10% povidone-iodine (group 4, n = 8). Computed tomography imaging of the thorax, indirect haemagglutination (IHA) titres and eosinophil counts were used to determine Cyst development. After 16 months, three control rabbits had pneumothorax, seven had Cysts and four had parenchymal nodules. Histopathological investigation of nodules revealed 87.5% Cyst formation. Pleural thickening was observed in rabbits from all groups. Cyst formation rates, IHA titres and eosinophilia counts were higher in group 1 than in groups 2-4. This study demonstrated the experimental formation of secondary Hydatidosis and found that topical protoscolocidal agents were beneficial in preventing Cyst recurrence.

Atilla Eroglu - One of the best experts on this subject based on the ideXlab platform.

  • An Unusual Cause of Pulmonary Arterial Hypertension: Hydatid Cyst.
    The Annals of Thoracic Surgery, 2020
    Co-Authors: Hayri Ogul, Selim Topcu, Yener Aydin, Ali Bilal Ulas, Mecit Kantarci, Atilla Eroglu
    Abstract:

    Hydatid Cyst is an important health problem throughout the world, and it is caused by the larval form of Echinococcus granulosus. Although it is most commonly located in the liver and Lungs, Hydatid Cyst can also affect other organs because the oncospheres spread through the bloodstream. The disease may have many different clinical presentations. Although it is a benign disease, sometimes it can cause serious morbidity and even mortality. Here, the case of a 33-year-old male patient who underwent surgery for a right ventricle and bilateral Lung Hydatid Cyst 9 years ago and had pulmonary hypertension is presented.

  • Lung Hydatid Cyst Treatment With Laparotomy: A New and Different Technique.
    The Annals of Thoracic Surgery, 2018
    Co-Authors: Yener Aydin, Ilker Ince, Atila Turkyilmaz, Atilla Eroglu
    Abstract:

    This report presents the case of a patient with a pulmonary Hydatid Cyst. The patient underwent laparotomy for hepatic and splenic Cysts, and Cystotomy and capitonnage were perfomed using a transdiaphragmatic intervention. The pulmonary Hydatid Cyst was located at the base of the Lung and near the diaphragm. The diaphragm was cut about 5 cm at the front, and the thorax was entered.The pulmonary Cyst was treated intraabdominally. This technique is effective and safe, and it prevents the patient from undergoing a second operation. The suggestion is that this technique, which has not been defined before, can be applied safely in carefully selected patients.

  • Pre-school children with Hydatid disease of Lung
    European Respiratory Journal, 2012
    Co-Authors: Yener Aydin, Hayri Ogul, Ali Bilal Ulas, Aysenur Dostbil, Omer Araz, Atilla Eroglu
    Abstract:

    Background: Hydatid Cyst is a major health problem in developing countries and it usually settled in Lungs in children. In this study we aimed to present our pre-school children cases with Lung Hydatid Cysts that we underwent surgical treatment. Methods: We retrospectively investigated 42 consecutive pre-school patients who were diagnosed and surgical treated for Hydatid Cysts in our clinic between January 1998 and December 2011. Results: Seventeen (40.5%) patients were female and 25 (%59.5) patients were male. The avarage age of the patients was 5.2±1.3 (between 2-7 ages). The most common symptoms were cough (%74), chest pain (%26,2) and fever (%26,2). Twenty eight cases' Cyst was in only one Lung, in five case Cyst was in single Lung and liver, in six cases Cyst was in bilateral Lungs and liver, in three cases Cyst was in bilateral Lungs. Avarage Cyst diameter was 6.2±2.4 (2-12 cm). It was interventioned to right Lung and liver Cysts by transdiaphragmatic approach together in five cases. In different seance operation was performed to nine patients with bilateral Cyst Hydatid. Muscle protector thoracotomy was performed in eight cases. Cystotomy and capitonnage were applied to all Lung Cysts. There was one case of postoperative atelectasis and bronchoscopy was performed. In one case, postoperative fever was observed. Postoperative mortality was not observed. Conlusion: Surgery is the definite treatment of Lung Hydatid Cyst. The most important way to ptrotect against adverse effects of thoracotomy is to eliminate routes of transmission. Keywords: Children, Lung hydatit Cyst.

  • Complications of albendazole treatment in Hydatid disease of Lung.
    European Journal of Cardio-Thoracic Surgery, 2002
    Co-Authors: Ibrahim Can Kurkcuoglu, Atilla Eroglu, Nurettin Karaoglanoglu, Pinar Polat
    Abstract:

    We present rupture of Lung Hydatid Cyst in a patient with multiple organ involvement during albendazole treatment. The patient was first provided mechanical ventilation than residue cavity and the other intact Cyst was treated surgically. We concluded that albendazole should be used in postoperative period in patients with Hydatid disease of the Lung to prevent recurrent disease.

  • Case report Complications of albendazole treatment in Hydatid disease of Lung
    2002
    Co-Authors: Ibrahim Can Kurkcuoglu, Atilla Eroglu, Nurettin Karaoglanoglu, Pinar Polat
    Abstract:

    We present rupture of Lung Hydatid Cyst in a patient with multiple organ involvement during albendazole treatment. The patient was first provided mechanical ventilation than residue cavity and the other intact Cyst was treated surgically. We concluded that albendazole should be used in postoperative period in patients with Hydatid disease of the Lung to prevent recurrent disease. q 2002 Elsevier Science B.V. All rights reserved.

Aliye Ceylan Zaralı - One of the best experts on this subject based on the ideXlab platform.

  • Liver Hydatid Cyst with Transdiaphragmatic Rupture and Lung Hydatid Cyst Ruptured into Bronchi and Pleural Space
    CardioVascular and Interventional Radiology, 2011
    Co-Authors: Bilgin Kadri Arıbaş, Gürbüz Dingil, Mert Köroğlu, Ümit Üngül, Aliye Ceylan Zaralı
    Abstract:

    The aim of this case study is to present effectiveness of percutaneous drainage as a treatment option of ruptured Lung and liver Hydatid Cysts. A 65-year-old male patient was admitted with complicated liver and Lung Hydatid Cysts. A liver Hydatid Cyst had ruptured transdiaphragmatically, and a Lung Hydatid Cyst had ruptured both into bronchi and pleural space. The patient could not undergo surgery because of decreased respiratory function. Both Cysts were drained percutaneously using oral albendazole. Povidone–iodine was used to treat the liver Cyst after closure of the diaphragmatic rupture. The drainage was considered successful, and the patient had no recurrence of signs and symptoms. Clinical, laboratory, and radiologic recovery was observed during 2.5 months of catheterization. The patient was asymptomatic after catheter drainage. No recurrence was detected during 86 months of follow-up. For inoperable patients with ruptured liver and Lung Hydatid Cysts, percutaneous drainage with oral albendazole is an alternative treatment option to surgery. The percutaneous approach can be life-saving in such cases.

Habib Thameur - One of the best experts on this subject based on the ideXlab platform.

  • Acute pulmonary embolism due to the rupture of a right ventricle hydatic Cyst.
    European Journal of Cardio-Thoracic Surgery, 2002
    Co-Authors: Hatem Lahdhili, Sabeur Hachicha, Mohamed Ziadi, Habib Thameur
    Abstract:

    Hydatid pulmonary embolism is an uncommon condition resulting from the rupture of a Hydatid heart Cyst or the opening of a visceral Hydatid Cyst (often in the liver) into the venous circulation. We report a case of Hydatid pulmonary embolism following rupture of a hydatic Cyst in the right ventricle. Pulmonary angiography showed right pulmonary occlusion. Echocardiography, computed tomography scan and magnetic resonance imaging showed images suggesting a Hydatid Cyst. The patient underwent sternotomy and cardiopulmonary bypass in order to treat the heart Cyst and remove the hydatic pulmonary obstruction. A concomitant Lung Hydatid Cyst was extirpated.

  • Case report Acute pulmonary embolism due to the rupture of a right ventricle hydatic Cyst
    2002
    Co-Authors: Hatem Lahdhili, Sabeur Hachicha, Mohamed Ziadi, Habib Thameur
    Abstract:

    Hydatid pulmonary embolism is an uncommon condition resulting from the rupture of a Hydatid heart Cyst or the opening of a visceral Hydatid Cyst (often in the liver) into the venous circulation. We report a case of Hydatid pulmonary embolism following rupture of a hydatic Cyst in the right ventricle. Pulmonary angiography showed right pulmonary occlusion. Echocardiography, computed tomography scan and magnetic resonance imaging showed images suggesting a Hydatid Cyst. The patient underwent sternotomy and cardiopulmonary bypass in order to treat the heart Cyst and remove the hydatic pulmonary obstruction. A concomitant Lung Hydatid Cyst was extirpated. q 2002 Published by Elsevier Science B.V.

Bahador Sarkari - One of the best experts on this subject based on the ideXlab platform.

  • Human Cystic echinococcosis in southwest Iran: a 15-year retrospective epidemiological study of hospitalized cases.
    Tropical Medicine and Health, 2020
    Co-Authors: Reza Shahriarirad, Amirhossein Erfani, Mehrdad Eskandarisani, Mohammad Rastegarian, Hajar Taghizadeh, Bahador Sarkari
    Abstract:

    Cystic echinococcosis (CE) is considered as a neglected disease with significant mortality and morbidity in most of the developing countries. The current study aimed to retrospectively assess the demographic and epidemiologic features of human CE surgical cases in a 15-year period in Fars province, southwestern Iran. A 15-year (2004–2018) retrospective study was conducted to find out the epidemiological and clinical picture of CE in patients who undergone surgeries for CE in two main hospitals in Fars Province, southwestern Iran. Hospital records were reviewed, and data were retrieved from each CE patient’s record. A total of 501 CE surgical cases were recorded during a 15-year period, corresponding to an average annual incidence of 33.4 and a surgical incidence rate of 0.74/100,000 population. Of these, 242 (48.6%) were male, and 256 (52.4%) were female. Patients’ age ranged from 2 to 96 years, with a mean age of 34.92 (± 19.87) years. A significantly higher rate of CE cases was noted in subject’s ≥ 50 years of age. The highest frequency of cases (62:12.5%) was recorded in the year 2017. The most commonly involved organs were liver (339 cases; 57.8%) and Lung (279 cases; 47.6%). Concurrent involvement of two organs was seen in 58 (9.9%) cases of both Lung and liver, 10 (1.6%) cases of Lung and other locations (but not liver), and 23 (3.9%) cases of liver and other locations (but not Lung). Reoperation was noted in 67 (13.4%) of the cases. The size of the Lung Hydatid Cyst varied, ranging between 2 and 24 cm (mean = 7.33, SD = 3.737). The size of liver Hydatid Cysts ranged from 1 to 26 cm (mean 9.04, SD = 4.275). The findings of the current study demonstrated a nearly constant prevalence of CE during the last 15 years in southern Iran. Further studies are needed to find out the reasons behind the recurrence of the disease, which is substantial, in surgically-treated patients.

  • Human Cystic echinococcosis in southwest Iran: a 15-year retrospective epidemiological study of hospitalized cases
    Tropical Medicine and Health, 2020
    Co-Authors: Reza Shahriarirad, Amirhossein Erfani, Mehrdad Eskandarisani, Mohammad Rastegarian, Hajar Taghizadeh, Bahador Sarkari
    Abstract:

    Background Cystic echinococcosis (CE) is considered as a neglected disease with significant mortality and morbidity in most of the developing countries. The current study aimed to retrospectively assess the demographic and epidemiologic features of human CE surgical cases in a 15-year period in Fars province, southwestern Iran. Methods A 15-year (2004–2018) retrospective study was conducted to find out the epidemiological and clinical picture of CE in patients who undergone surgeries for CE in two main hospitals in Fars Province, southwestern Iran. Hospital records were reviewed, and data were retrieved from each CE patient’s record. Results A total of 501 CE surgical cases were recorded during a 15-year period, corresponding to an average annual incidence of 33.4 and a surgical incidence rate of 0.74/100,000 population. Of these, 242 (48.6%) were male, and 256 (52.4%) were female. Patients’ age ranged from 2 to 96 years, with a mean age of 34.92 (± 19.87) years. A significantly higher rate of CE cases was noted in subject’s ≥ 50 years of age. The highest frequency of cases (62:12.5%) was recorded in the year 2017. The most commonly involved organs were liver (339 cases; 57.8%) and Lung (279 cases; 47.6%). Concurrent involvement of two organs was seen in 58 (9.9%) cases of both Lung and liver, 10 (1.6%) cases of Lung and other locations (but not liver), and 23 (3.9%) cases of liver and other locations (but not Lung). Reoperation was noted in 67 (13.4%) of the cases. The size of the Lung Hydatid Cyst varied, ranging between 2 and 24 cm (mean = 7.33, SD = 3.737). The size of liver Hydatid Cysts ranged from 1 to 26 cm (mean 9.04, SD = 4.275). Conclusion The findings of the current study demonstrated a nearly constant prevalence of CE during the last 15 years in southern Iran. Further studies are needed to find out the reasons behind the recurrence of the disease, which is substantial, in surgically-treated patients.

  • Human Cystic echinococcosis in southwest Iran: a 15-year retrospective epidemiological analysis of 501 consecutive hospitalized cases (2004-2018)
    2019
    Co-Authors: Reza Shahriarirad, Amirhossein Erfani, Mehrdad Eskandarisani, Mohammad Rastegarian, Hajar Taghizadeh, Bahador Sarkari
    Abstract:

    Abstract Background: Cystic echinococcosis (CE) is considered a neglected disease with significant mortality and morbidity in most of the developing countries. The current study aimed to retrospectively assess the epidemiologic and clinical features of human CE in a 15-year period in Fars province, southwestern Iran. Methods: Hospital records of patients undergone surgeries for CE in two main hospitals in Fars Province, southwestern Iran in a 15-year period (2004-2018) were reviewed and data concerning the patients' demographical and clinical features were retrieved from each record. Results: A total of 501 CE surgical cases were recorded during a 15-year period, giving an average annual incidence of 33.4 cases in which 242 (48.6%) were male and 256 (52.4%) were female. Patients' age ranged from 2 to 96 years, with a mean age of 34.92 (±19.87) years. A significantly higher rate of CE cases was noted in subjects ≥ 50 years of age. The highest frequency of cases (62: 12.5%) was recorded in the year 2017. The most commonly involved organs were liver (339 cases; 57.8%), and Lung (279 cases; 47.6%). Concurrent involvement of two organs was seen in 58 (9.9%) cases of both Lung and liver, 10 (1.6%) cases of Lung and other locations (but not liver) and 23 (3.9%) cases of liver and other locations (but not Lung). Recurrence was noted in 67 (13.37%) of the cases. The size of the Lung Hydatid Cyst varied, ranging between 2 to 24 cm (mean = 7.33, SD= 3.737). The size of liver Hydatid Cysts ranged from 1 to 26 cm (mean: 9.04, SD= 4.275). Conclusion: The findings of the current study demonstrated a nearly constant prevalence of CE during the last 15 years in southern Iran. Further studies are needed to find out the reasons behind the recurrence of the disease, which is substantial, in surgically-treated patients.